ZLAB

Zai Lab
ZLAB

Latest price

Financial Snapshot

gainify

Market Data

Market Cap
$3.69B
EV
$3.07B
Shares Outstanding
111.47M
Beta
1.09

Wall Street View

Analyst Rating
BUY
Analyst Target Price
$54.87
P/E 2025E
-
P/Revenue 2025E
6.52x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Zai Lab Limited

gainify
ZLAB

Zai Lab Limited

ZLAB

Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience. Its commercial products include Zejula, an orally administered poly polymerase 1/2 inhibitor; Optune, a cancer therapy that uses elect...

Sector

Healthcare

Industry

Biotechnology

CEO

Du, Ying

Employees

1,869

IPO Date

2017-09-20

Headquarters

Jinchuang Plaza, Building 1, Fourth Floor, 4560 Jinke Road, Pudong, Shanghai 201210, China

gainify
mailcontactcontact
powered-by-sp

NEWSLETTER

COMPANY

© Copyright 2025, All Rights Reserved